NasdaqCM:CPRXBiotechs
Does Catalyst Pharmaceuticals Still Offer Value After Its 559.8% Five Year Surge in 2025?
Wondering if Catalyst Pharmaceuticals is still a smart buy after its big run, or if the best gains are already behind it? Let us unpack whether the current price really matches what the business is worth.
The stock has delivered a modest 0.4% gain over the last week and 3.7% over the past month, but zooming out shows a stronger 9.8% year to date and a massive 559.8% over five years. This naturally raises questions about how much upside is left.
Recent attention around Catalyst has focused on...